Bandingkan Harga & Kinerja Garuda Indonesia (Persero) Tbk. (GIAA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Garuda Indonesia (Persero) Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Garuda Indonesia (Persero) Tbk. diperdagangkan di Rp72 (kapitalisasi pasar 29,31 T), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M). Perbedaan utamanya: Garuda Indonesia (Persero) Tbk. jauh lebih besar — sekitar 178× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GIAA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 29,31 T | 164,65 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Garuda Indonesia (Persero) Tbk.
The Company is a state-owned airline of the republic of Indonesia and commercial air transportation service provider for passenger, cargo, and other services related to air transportation in Indonesia. The Company also provides services related aviation services, including repairs, maintenance and overhaul (MRO), aircraft, ground services, air tickets reservation and provision, and in fight catering, as well as travel services, tourism and hospitality.The Company was established on March 31, 1950 with the name of Garuda Indonesian Airways NV domiciled in Central Jakarta. In accordance with government regulations, in 1975 the company changed its form a Limited Liability Company (Persero) PT Garuda Indonesian Airways.
Selengkapnya di halaman GIAA →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
